NNOX

REMINDER: Nano-X Imaging Ltd. Investors With Significant Losses Must Act By August 11, 2026

Nano-X faces August lead-plaintiff deadline; potential downside risk to NNOX

<section class="insight" data-version="1">
  <section data-block="information">
    <h3>Information</h3>
    <p>&lt;link type=&quot;text/css&quot; rel=&quot;stylesheet&quot; href=&quot;https://www.globenewswire.com/styles/gnw_nitf.css&quot;&gt;&lt;/li...</p>
  </section>

  <section data-block="ai-summary-paragraph">
    <h3>AI Summary</h3>
    <p>Nano-X Imaging faces an August 11, 2026 deadline to appoint a lead plaintiff in a pending securities class action. The suit targets alleged overstatements of efficiency gains and misalignment of production with demand, implying higher costs and cash burn. With a $33.4 million Q4 loss and a $17.5 million impairment at the Korean facility, plus a CFO departure, the legal development could pressure NNOX sentiment and valuation in the near term.</p>
  </section>

  <section data-block="ai-summary-bullets">
    <h3>Key Points</h3>
    <ul><li>Nano-X lead plaintiff deadline set for August 11, 2026.</li><li>Lawsuit alleges overstated efficiency gains and demand misalignment.</li><li>Q4 2025 net loss of $33.4 million with $17.5 million impairment at Korea facility.</li><li>CFO Ran Daniel to resign effective July 31, 2026; CEO highlights outsourcing shift.</li><li>Nano-X shares fell about 25% after the April 2026 results; legal overhang persists.</li></ul>
  </section>

  <section data-block="companies-mentioned">
    <h3>Companies Mentioned</h3>
    <ul><li><strong>Nano-X Imaging Ltd (NNOX)</strong>: Subject of securities class action; potential material legal, financial, and reputational impact; overhang on stock.</li><li><strong>Kirby McInerney LLP (KM-LLP)</strong>: Plaintiff law firm leading the class action; could influence litigation strategy and publicity, indirect effect on investor sentiment.</li></ul>
  </section>

  <section data-block="category">
    <h3>Legal</h3>
    <p>Legal; the item centers on a securities class action and lead-plaintiff process, with potential cost, settlement, and sentiment implications for Nano-X.</p>
  </section>

  <section data-block="market-moving">
    <h3>Market-Moving</h3>
    <ul><li>August 11, 2026 lead-plaintiff deadline could trigger near-term volatility.</li><li>Q4&#039;25 results showed a $33.4M net loss and $17.5M impairment charge.</li><li>CFO transition effective July 31, 2026 signaling cost/operational adjustments.</li><li>Historic 25% drop post-earnings highlights sensitivity to legal/news catalysts.</li></ul>
  </section>

  <section data-block="key-facts">
    <h3>Key Facts</h3>
    <ul><li>Aug 11, 2026: deadline to seek lead plaintiff in Nano-X securities class action.</li><li>Class Period: Mar 31, 2025 through Apr 17, 2026.</li><li>Q4 2025 net loss: $33.4 million.</li><li>Impairment charge: $17.5 million related to Korean facility.</li><li>CFO Ran Daniel to resign effective July 31, 2026.</li></ul>
  </section>

  <section data-block="trading-thesis">
    <h3>Trading Thesis</h3>
    <p>Bearish near-term risk for NNOX on legal overhang; monitor August 11, 2026 for settlements or new facts.</p>
  </section>
</section>


<article>
  <p><strong>New York</strong>, July 7, 2026 — Nano-X Imaging Ltd. <strong>NNOX</strong> investors are reminded of the <strong>August 11, 2026</strong> deadline to seek the role of lead plaintiff in a pending federal securities class action. Filed by Kirby McInerney LLP, the suit covers the period from <strong>March 31, 2025</strong> through <strong>April 17, 2026</strong>, inclusive. The lead plaintiff would oversee the litigation on behalf of the class and may influence key decisions, including litigation strategy and settlement. Courts regularly appoint individual investors as lead plaintiffs, not only institutions. Learn more about the lead plaintiff process and eligibility requirements <a href="https://www.globenewswire.com/Tracker?data=Y4vrMpO2oprpxz7rKbA6CqEiNeQI3fEsU6NNLJuWUTtsno9wxpexse92F2EFIoD4fpN0TZmQUS3Lw_BcvSvzUMhijOnuv9zpQPqcj12bm8Y=" target="_blank" rel="nofollow">here</a>.</p>

  <section>
    <h2>Lawsuit Overview and Class Period</h2>
    <p>The lawsuit has been filed on behalf of investors who purchased securities during the period of <strong>March 31, 2025</strong> through <strong>April 17, 2026</strong>, inclusive (<em>the Class Period</em>). The allegations include: (i) Nano-X overstated purported efficiency gains achieved in its operations, as well as the purported increased demand for its products; (ii) in reality, Nano-X’s production and manufacturing operations were poorly aligned with demand for the Company’s products; (iii) as a result, Nano-X was experiencing significantly increased operating expenses and cash burn; and (iv) the foregoing significantly increased the likelihood that Nano-X would be forced to take disruptive remedial measures with respect to its manufacturing operations, entailing significant restructuring and impairment charges.</p>

    <p>If you purchased or otherwise acquired Nano-X securities, have information, or would like to learn more, please contact <a href="https://www.globenewswire.com/Tracker?data=QPAi4DK57jvSOCMZ9b7D4LJZoEExDdU-V35HVdQah2lwW1zHBHsvnSOH7Rle6tihtbeWE42pIwRUHE9SbZpoMKvUqZMSjmEiWE9vcpssO8oTzPZXP0VQyTOjU2EKEbJO" target="_blank" rel="nofollow">Lauren Molinaro</a> of Kirby McInerney LLP by email at <a href="https://www.globenewswire.com/Tracker?data=UpuCB8N0GS3fWaxwih9Mki4kplP12P-jC8aQAJ-g9IRsqH7e8jsM41kIBwnC3TA0_Uz7bjYSeqNTBmWs8JuvLjUk0GfFodUBFUSsZcKwgDxWBLRnIz9mi__DtIrSRN8m" target="_blank" rel="nofollow">investigations@kmllp.com</a>, or fill out the form below, to discuss your rights or interests.</p>

    <p style="text-align:center">[<a href="https://www.globenewswire.com/Tracker?data=l2m-NBdrd_K2RzAiqYLDhXfDgHo_Ojaic1rXc2o655BHExJ5EdtLE6qMyBpkypxrF-WBGXMot345yDQEHqitNBtDEZOBC13lX78a5HHhTgfvasET47D5Q7DRXUk34WSlx9ewVp-5-pgf5ILelefE4RRjyagw8XxxY0l2VUxHwgI=" target="_blank" rel="nofollow">CONTACT THE FIRM IF YOU SUFFERED A LOSS</a>]</p>

    <p><strong>What Is The Lawsuit About?</strong></p>
    <p>The lawsuit has been filed on behalf of investors who purchased securities during the period of <strong>March 31, 2025</strong> through <strong>April 17, 2026</strong>, inclusive (<em>the Class Period</em>). The lawsuit alleges that (i) Nano-X overstated purported efficiency gains achieved in its operations, as well as the purported increased demand for its products; (ii) in reality, Nano-X’s production and manufacturing operations were poorly aligned with demand for the Company’s products; (iii) as a result, Nano-X was experiencing significantly increased operating expenses and cash burn; and (iv) the foregoing significantly increased the likelihood that Nano-X would be forced to take disruptive remedial measures with respect to its manufacturing operations, entailing significant restructuring and impairment charges.</p>
  </section>

  <section>
    <h2>Q4 2025 Results and Management Commentary</h2>
    <p>On <strong>April 20, 2026</strong>, Nano-X issued a press release announcing its Q4 2025 financial results and business updates. Nano-X reported, <em>inter alia</em>, a Q4 net loss of <strong>$33.4 million</strong>, mainly due to a <strong>$17.5 million</strong> charge attributed to impairment of long-lived assets following a restructuring initiative at its Korean chip manufacturing facility. In explaining the restructuring charge, the press release acknowledged that Nano-X needed to "shift[] to a more efficient outsourced production model that is better aligned with current and anticipated demand." The same press release also announced that Nano-X’s then-Chief Financial Officer ("CFO"), Ran Daniel, would step down as CFO, effective <strong>July 31, 2026</strong>. The same day, during a related earnings call to discuss these results, Nano-X’s Chief Executive Officer, Erez Meltzer, likewise disclosed that Defendants needed "to reduce our Korean operation’s OpEx [operating expenses] and cash burn and improve efficiency", while reiterating the need to "transition to a more efficient outsourced production model better aligned with current and projected demand." On this news, the price of Nano-X shares declined by <strong>$0.70</strong> per share, or approximately <strong>25%</strong>, from <strong>$2.85</strong> per share on <strong>April 17, 2026</strong> to close at <strong>$2.15</strong> on <strong>April 20, 2026</strong>.</p>

    <p>[<a href="https://www.globenewswire.com/Tracker?data=Kx52ckJ79QSrjzzipYwYTkSjy51knaWf4tiZEA-MWRPeeum6QNKN0lBm6jchvKFqDUyhvgtwOCaIzMXURXP9JlbHavnreqy-6w5DCO37_OzmcwE8GotiNHdDO89pLsGth-W6ID6z5ZumGK9H1FC8kWNcB29-IPR4QtIH_7kjFwnsrspCOMIBnUjnCFjsqyDk" target="_blank" rel="nofollow">CLICK HERE TO LEARN MORE ABOUT THE CLASS ACTION</a>]</p>
  </section>

  <section>
    <h2>What Should I Do? Guidance for Investors</h2>
    <p>If you purchased or otherwise acquired Nano-X securities, have information, or would like to learn more about this investigation, please contact <a href="https://www.globenewswire.com/Tracker?data=QPAi4DK57jvSOCMZ9b7D4DbAKIq3SdydWsUePVrRvtM5ES0Dm8hWhVs5JUmI2-PdYbA-j62ObN9fEC5FB6QZryH-G8VTm2iPxHxtahgo00wjt72AsRXKugxDQaRxhpAf" target="_blank" rel="nofollow">Lauren Molinaro</a> of <a href="https://www.globenewswire.com/Tracker?data=g0dykSVOrGfwTz_8-m1GgldCncV_-u4R2dqZl1CnAuYIBAUD3AlVljLhUvyk3UJTkh4tTouTk0zNIpiaN7lAY9hAu2Q9zrpiMaWrDTSzkJY=" target="_blank" rel="nofollow">Kirby McInerney LLP</a> by email at <a href="https://www.globenewswire.com/Tracker?data=UpuCB8N0GS3fWaxwih9Mki4kplP12P-jC8aQAJ-g9ISQkoL0oDsiq9TWGj2WyzASYjMXLaplV076d0ywUGxAX-SRM-8OgvCyy8GfNIuH7QBIt35adzZC_aNN324pwUUg" target="_blank" rel="nofollow">investigations@kmllp.com</a>, or fill out the contact form below, to discuss your rights or interests with respect to these matters at no cost.</p>

    <p>[<a href="https://www.globenewswire.com/Tracker?data=_i4jheQFB50qV8hgskOfd5_jnin1tcwGH3km7IbW-fejrjIZuiq4x7BFbTfsSrcIOg3wdl10WYrl6bcgTJvDjYS6553WYf9SHz_SFMDyRk_VrpKje7yeE129oY4ikAQXqq2Q1tMIo8Ao_nSh9_4JAw==" target="_blank" rel="nofollow">WHAT IS A SECURITIES CLASS ACTION?</a>]</p>

    <p><a href="https://www.globenewswire.com/Tracker?data=g0dykSVOrGfwTz_8-m1GgozOFJud7IhtWJW6M2elUJqMjiu2pqpLp_DlD9LljgD08whe89b1RdjXtzo67qhewRdxr3Op2qkRZldLE_ep0VY=" target="_blank" rel="nofollow">Kirby McInerney LLP</a> is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP’s <a href="https://www.globenewswire.com/Tracker?data=vJ7DeWnFOHvmLLgsUts1iT-Y5pOUP5OfPAbQ0mqSaDH68nkTlOR-jkphKSvxRmvJ5jWzirMYobXYHa8hw36wcQ==" target="_blank" rel="nofollow">website</a>.</p>

    <p>This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.</p>

    <p>Contacts<br>
    Kirby McInerney LLP<br>
    Lauren Molinaro, Esq.<br>
    212-699-1171<br>
    <a href="https://www.globenewswire.com/Tracker?data=P1ka3ubxXvt8zwbkY9u6kp8q5CQNAmd6lL22HHGqMvNTbFf4niRR0_7aaLcWgA9xZdTR2aGHEeKHyIuUVmlp7bwnHH0TCqxkqV6SXAmH_vw=" target="_blank" rel="nofollow">https://www.kmllp.com</a><br>
    <a href="https://www.globenewswire.com/Tracker?data=P1ka3ubxXvt8zwbkY9u6kleUkKKiUV30P3xlu2gJvlZWOBFYR4Tji-xeNhIWtW76oaa8hIZEF5l0ZbbHzdSs8vUR6uZ_322iOsMvS__XcDeSC4HJexHIiyThVQBaFgCSgm1CQxxFuLE5c29Kg9a9cg==" target="_blank" rel="nofollow">https://securitiesleadplaintiff.com/</a><br>
    <a href="https://www.globenewswire.com/Tracker?data=UpuCB8N0GS3fWaxwih9Mki4kplP12P-jC8aQAJ-g9ITg_8VfY0Ix1EOMWj054Gri5fmh-SRJxHI7MN4i72WIMfVEjkpYJsidKgaktO02i7Bdo92o4gCWu21_P6-0VcM4" target="_blank" rel="nofollow">investigations@kmllp.com</a></p>
  </section>

  <section>
    <p style="text-align:center">[<em>This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.</em>]</p>
  </section>

  <section>
    <p>This article summarizes a regulatory filing and legal matter. For further details, refer to the original Globe Newswire release distributed by Kirby McInerney LLP on behalf of Nano-X Imaging Ltd.</p>
  </section>
</article>

Nano-X Imaging faces an August 11, 2026 deadline to appoint a lead plaintiff in a pending securities class action. The suit targets alleged overstatements of efficiency gains and misalignment of production with demand, implying higher costs and cash burn. With a $33.4 million Q4 loss and a $17.5 million impairment at the Korean facility, plus a CFO departure, the legal development could pressure NNOX sentiment and valuation in the near term.

REMINDER: Nano-X Imaging Ltd. Investors With Significant Losses Must Act By August 11, 2026

AI Summary

Sentiment Rationale

Trading Thesis

Market-Moving

Key Facts

Companies Mentioned

Legal

Related News